Please wait a minute...
浙江大学学报(医学版)  2016, Vol. 45 Issue (4): 342-348    DOI: 10.3785/j.issn.1008-9292.2016.07.03
癌分子医学专题     
微RNA-let-7e-3p在宫颈上皮内瘤变和宫颈癌组织中的表达及临床意义
陈晓静, 许君芬, 叶菁, 程晓东, 谢幸, 吕卫国
浙江大学医学院附属妇产科医院中心实验室 浙江省女性生殖健康研究重点实验室, 浙江 杭州 310006
Expression of miR-let-7e-3p in cervical intraepithelial neoplasm and cervix carcinoma and its clinical significance
CHEN Xiaojing, XU Junfen, YE Jing, CHENG Xiaodong, XIE Xing, LYU Weiguo
Central Laboratory, Women's Hospital, Zhejiang University School of Medicine, Key Laboratory of Women's Reproductive Health of Zhejiang Province, Hangzhou 310006, China
全文: PDF(1118 KB)  
摘要: 

目的:探索微RNA(miRNA,miR-)-let-7e-3p在不同宫颈病变中表达情况及临床意义。方法:收集并整理具有完整临床病理资料的病例,其中正常子宫颈26例、子宫颈高级别鳞状上皮内病变(HSIL)37例、宫颈癌101例;采用实时定量RT-PCR检测临床宫颈组织样本中miR-let-7e-3p的相对表达量,分析miR-let-7e-3p表达水平与宫颈癌的发生及临床不良预后因素间的相关性。将miR-let-7e-3p模拟物转染至宫颈癌细胞株Siha(转染组),采用流式细胞仪检测Siha细胞周期和细胞凋亡变化;CCK-8试剂盒检测Siha细胞增殖变化;Transwell实验检测Siha细胞迁移和侵袭能力变化。结果:miR-let-7e-3p在正常宫颈、HSIL及宫颈癌组织中的相对表达量分别为1.45±0.24、0.79±0.05、0.46±0.04,正常子宫颈与HSIL、正常子宫颈与宫颈癌、HSIL与宫颈癌相对表达量差异均具有统计学意义(均P<0.05);miR-let-7e-3p表达水平与患者宫颈癌临床不良预后因素之间无显著相关性;转染组S期细胞(29.76%±6.60%)高于阴性对照组(13.38%±1.30%,P<0.05);转染组凋亡率(5.98%±1.38%)高于阴性对照组(3.53%±0.79%,P<0.05);转染组转染后48、72、96 h吸光度值分别为0.57±0.11、0.65±0.04、0.84±0.14,阴性对照组为0.74±0.05、0.93±0.10、1.47±0.14,细胞增殖均被抑制(均P<0.05);转染组与阴性对照组迁移和侵袭能力差异均无统计学意义(均P>0.05)。结论:miR-let-7e-3p可能在宫颈癌的发生中发挥抑癌基因的作用,阻滞细胞周期和抑制细胞增殖可能是其重要调控机制。

关键词 微RNAs宫颈肿瘤/病理学宫颈上皮内瘤样病变/病理学基因,肿瘤抑制细胞周期细胞增殖基因表达逆转录聚合酶链反应    
Abstract

Objective: To investigate the expression of microRNA (miRNA, miR) let-7e-3p in different cervical lesions and its clinical significance. Methods: The expression of miR-let-7e-3p in the tissues of normal cervix (n=26), high-grade squamous intraepithelial lesion (HSIL) (n=37), and cervix carcinoma (n=101) were detected by reverse transcription and quantitative polymerase chain reaction (RT-qPCR). The correlation of miR-let-7e-3p expression with the clinicopathological parameters of patients with cervical cancer was analyzed. miR-let-7e-3p mimic was transfected into cervical carcinoma Siha cells. The cell cycle and apoptosis were determined by flow cytometry; cell proliferation was determined by CCK-8 kit; and the migration and invasion of cells were determined by Transwell assay. Results: The relative expression levels of miR-let-7e-3p in normal cervix, HSIL, and cervical carcinoma were 1.45±0.24, 0.79±0.05 and 0.46±0.04, respectively (all P<0.05). After transfection with miR-let-7e-3p mimic, the S-phase fraction and apoptosis rate of Siha cells were increased significantly compared with control group[(29.76±6.6)% vs (13.38±1.3)%, P<0.05; (5.98±1.38)% vs (3.53±0.79)%, P<0.05, respectively]. OD of transfected Siha cells at 48, 72 and 96 h were 0.57±0.11,0.65±0.04 and 0.84±0.14, which were significantly lower than those of untransfected Siha cells (0.74±0.05, 0.93±0.10 and 1.47±0.14, all P<0.05). The migration and invasion abilities of transfected Siha cells were not significantly changed (all P>0.05). Conclusion: The expression of miR-let-7e-3p is down-regulated in cervical neoplasms, which is associated with cell cycle arrest and proliferation inhibition of cervical cancer cells.

Key wordsMicroRNAs    Uterine cervical neoplasms/pathology    Cervical intraepithelial neoplasia/pathology    Genes, tumor suppressor    Cell cycle    Cell proliferation    Gene expression    Reverse transcriptase polymerase chain reaction
收稿日期: 2015-08-11
CLC:  R737.33  
基金资助:

国家自然科学基金(81472421,81272861);浙江省自然科学基金(LQ15H160003);国家重点研发计划“重大慢性非传染性疾病防控研究”重点专项(2016YFC1302900,2016YFC0902900)

通讯作者: 吕卫国(1965-),博士,主任医师,教授,博士生导师,主要从事妇科肿瘤临床和基础研究;E-mail:lbwg@zju.edu.cn;http://orcid.org/0000-0002-8570-7317     E-mail: lbwg@zju.edu.cn
作者简介: 陈晓静(1986-),学士,技师,主要从事妇科肿瘤基础研究;E-mail:rj045wwq@163.com;http://orcid.org/0000-0001-8107-9037
服务  
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章  

引用本文:

陈晓静 等. 微RNA-let-7e-3p在宫颈上皮内瘤变和宫颈癌组织中的表达及临床意义[J]. 浙江大学学报(医学版), 2016, 45(4): 342-348.
CHEN Xiaojing, XU Junfen, YE Jing, CHENG Xiaodong, XIE Xing, LYU Weiguo. Expression of miR-let-7e-3p in cervical intraepithelial neoplasm and cervix carcinoma and its clinical significance. Journal of ZheJiang University(Medical Science), 2016, 45(4): 342-348.

链接本文:

http://www.zjujournals.com/xueshu/med/CN/10.3785/j.issn.1008-9292.2016.07.03      或      http://www.zjujournals.com/xueshu/med/CN/Y2016/V45/I4/342

[1] TORRE L A, BRAY F, SIEGEL R L, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin,2015,65(2):87-108.
[2] ARBYN M, CASTELLSAGUE X, DE S S, et al. Worldwide burden of cervical cancer in 2008[J]. Ann Oncol,2011,22(12):2675-2686.
[3] LI Y,WANG F F, XU J F, et al. Progressive miRNA expression profiles in cervical carcinogenesis and identification of HPV-related target genes for miR-29[J]. J Pathol,2011, 224(4):484-495.
[4] XU J F, LI Y, WANG F F, et al. Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of invasive cervical cancer[J]. Oncogene,2013,32(8):976-987.
[5] VILLEGAS R V, JUAREZ M S, PEREZ G O, et al. Heterogeneity of microRNAs expression in invasive cervical cancer cells: over-expression of miR-196a[J]. Int J Clin Exp Pathol,2014,7(4):1389-1401.
[6] ROUSH S, SLACK F J. The let-7 family of microRNAs[J]. Trends Cell Biol, 2008,18(10):505-516.
[7] BOYERINAS B, PARK S M, HAU A, et al. The role of let-7 in cell differentiation and cancer[J]. Endocr Relat Cancer,2010,17(1):F19-36.
[8] CHIU S C, CHUNG H Y, CHO D Y, et al. Therapeutic potential of microRNA let-7: tumor suppression or impeding normal stemness[J]. Cell Transplant,2014,23(4-5):459-469.
[9] TAKAMIZAWA J, KONISHI H, YANAGISAWA K, et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival[J]. Cancer Res, 2004,64(11):3753-3756.
[10] YANAIHARA N, CAPLEN N, BOWMAN E, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis[J]. Cancer Cell, 2006,9(3):189-198.
[11] SCHMITTGEN T D, LIVAK K J. Analyzing real-time PCR data by the comparative CT method[J]. Nat Protoc, 2008, 3(6):1101-1108.
[12] KONG Y W, FERLAND-MCCOLLOUGH D, JACKSON T J, et al. microRNAs in cancer management[J]. Lancet Oncol, 2012, 13(6):e249-258.
[13] MO Y Y. MicroRNA regulatory networks and human disease[J]. Cell Mol Life Sci, 2012, 69(21):3529-3531.
[14] REINHART B J, SLACK F J, BASSON M, et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans[J]. Nature,2000,403(6772):901-906.
[15] JOHNSON C, ESQUELA K A, STEFANI G, et al. The let-7 microRNA represses cell proliferation pathways in human cells[J]. Cancer Res,2007,67(16):7713-7722.
[16] CHANG C J, HSU C C, CHANG C H, et al. Let-7d functions as novel regulator of epithelial-mesenchymal transition and chemoresistant property in oral cancer[J]. Oncol Rep,2011,26(4):1003-1010.
[17] WANGNER S, NGEZAHAYO A, MURUA E H, et al. Role of miRNA let-7 and its major targets in prostate cancer[J]. Biomed Res Int,2014,2014: 376326.
[18] ZHAO B, HAN H, CHEN J, et al. MicroRNA let-7c inhibits migration and invasion of human non-small cell lung cancer by targeting ITGB3 and MAP4K3[J]. Cancer Lett,2014,342(1):43-51.
[19] HUR K, TOIYAMA Y, SCHETTER A J, et al. Identification of a metastasis-specific MicroRNA signature in human colorectal cancer[J]. J Nat Cancer Inst,2015,107(3):dju492.
[1] 杨晓红 等. 微RNA-705对MC3T3-E1细胞成骨分化能力的影响[J]. 浙江大学学报(医学版), 2016, 45(6): 575-580.
[2] 候仕芳 等. 下调lmna基因对斑马鱼胚胎髓系和红系造血干细胞发育的影响[J]. 浙江大学学报(医学版), 2016, 45(6): 620-625.
[3] 吴志华 等. 异基因造血干细胞移植受者T细胞受体β链CDR3谱型表达与巨细胞病毒激活[J]. 浙江大学学报(医学版), 2016, 45(5): 515-521.
[4] 曹鹏 等. 双氢青蒿素抗肿瘤分子生物学机制研究进展[J]. 浙江大学学报(医学版), 2016, 45(5): 501-507.
[5] 杨肃文 等. 意义未明单克隆免疫球蛋白病及多发性骨髓瘤患者微RNA-221和微RNA-222的表达[J]. 浙江大学学报(医学版), 2016, 45(4): 371-378.
[6] 娄鹏荣 等. 靶向RAD18的小干扰RNA对人食管鳞癌ECA-109细胞增殖和化疗敏感性的影响[J]. 浙江大学学报(医学版), 2016, 45(4): 364-370.
[7] 林伟仁 等. zeste基因增强子同源物2抑制剂GSK126对前列腺癌细胞的作用及机制[J]. 浙江大学学报(医学版), 2016, 45(4): 356-363.
[8] 王程 等. 微RNA:一类新的椎间盘退变调控因子[J]. 浙江大学学报(医学版), 2016, 45(2): 170-178.
[9] 杨婉花等. MicroRNA-150联合脉搏指示连续性心输出量检测指标判断脓毒症休克患者预后的临床价值[J]. 浙江大学学报(医学版), 2015, 44(6): 659-664.
[10] 杨燕, 李玉梅, 张娜, 李皖云, 欧玉荣, 汪蕊, 赵福友, 吴穷. 缝隙连接蛋白26在肝细胞癌组织的表达及意义[J]. 浙江大学学报(医学版), 2015, 44(5): 517-524.
[11] 赵遵兰等. 微小RNA-21对人乳腺癌细胞株紫杉醇耐药性的影响及其机制[J]. 浙江大学学报(医学版), 2015, 44(4): 400-409.
[12] 辛廖冰, 江秀秀, 叶小磊, 吴瑞瑾, 徐开红, 马俊彦, 林俊. 稳定沉默水通道蛋白5基因对异位子宫内膜腺上皮细胞增殖及迁移的影响[J]. 浙江大学学报(医学版), 2015, 44(3): 285-292.
[13] 王小军, 张浩, 詹红生, 丁道芳. 应用大鼠血清建立体外软骨细胞退变模型[J]. 浙江大学学报(医学版), 2015, 44(3): 308-314.
[14] 韩艳霞, 尤良顺, 刘辉, 毛莉萍, 叶琇锦, 钱文斌. 细胞周期蛋白依赖激酶抑制剂诱导HL-60细胞凋亡及分子机制研究[J]. 浙江大学学报(医学版), 2015, 44(2): 174-178.
[15] 郑永霞,张成文,惠斌,等. 磷脂酰肌醇3激酶调节亚基基因对HepG2细胞增殖的影响[J]. 浙江大学学报(医学版), 2014, 43(5): 559-.